CureVac COVID vaccine let-down spotlights mRNA design challenges

Elie Dolgin • June 18, 2021

Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines.

Two vaccines made using messenger RNA (mRNA) have proved spectacularly successful at warding off COVID-19, but a third mRNA-based candidate has flopped in a final-stage trial, according to an initial report released this week.


Researchers are now asking why — and some think that choices about the type of mRNA chemistry used might be to blame. Any insight could help to guide the future design of mRNA vaccines against COVID-19 or other diseases.


Continue reading at Nature.

By Elie Dolgin September 25, 2025
Language model delivers predictions that rival years of lab work.
Man in military uniform administering a vaccine into the arm of another man.
By Elie Dolgin September 24, 2025
The Department of Defense is continuing to bankroll projects to develop vaccines against deadly pathogens.